Description
Contents
Amlodipine/Valsartan/HCTZ
Indications/Uses
Treatment of essential hypertension.
This fixed combination drug is not indicated for the initial therapy of hypertension
Dosage/Direction for Use
A patient whose blood pressure is not adequately controlled on dual therapy may be directly switched to combination therapy with Exforge HCT.
For convenience, patients receiving valsartan, amlodipine and HCTZ from separate tablets may be switched to Exforge HCT containing the same component doses. A patient who experiences dose limiting adverse reactions on any dual combination of the components of Exforge HCT may be switched to Exforge HCT containing a lower dose of that component to achieve similar blood pressure reductions.
Dosage may be increased after two weeks. The maximum antihypertensive effect of Exforge HCT is reached within two weeks after a change in dose. The maximum recommended dose of Exforge HCT is 10/320/25 mg.
For convenience, patients receiving valsartan, amlodipine and HCTZ from separate tablets may be switched to Exforge HCT containing the same component doses. A patient who experiences dose limiting adverse reactions on any dual combination of the components of Exforge HCT may be switched to Exforge HCT containing a lower dose of that component to achieve similar blood pressure reductions.
Dosage may be increased after two weeks. The maximum antihypertensive effect of Exforge HCT is reached within two weeks after a change in dose. The maximum recommended dose of Exforge HCT is 10/320/25 mg.
*The product images shown are for illustration purposes only and may not be an exact representation of the product.
